Showing results (161-170 of 260) with videos related to

Sort By:
Pageof 26
The Journal of Biological Chemistry|August 26, 1998
A novel phosphopantetheine:protein transferase activating yeast mitochondrial acyl carrier proteinH P Stuible, S Meier, C Wagner, et al.
Archives of General Psychiatry|May 1, 1988
Long-term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspironeK Rickels, E Schweizer, I Csanalosi, et al.
Clinical Pharmacology and Therapeutics|June 19, 1998
Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extractionH P Platten, E Schweizer, K Dilger, et al.
Bioscience Reports|April 1, 1987
Docking of chromaffin granules--a necessary step in exocytosis?T Schäfer, U O Karli, F E Schweizer, et al.
FEBS Letters|August 14, 1995
DNA binding site of the yeast heteromeric Ino2p/Ino4p basic helix-loop-helix transcription factor: structural requirements as defined by saturation mutagenesisH J Schüller, K Richter, B Hoffmann, et al.
The EMBO Journal|January 1, 1992
Coordinate genetic control of yeast fatty acid synthase genes FAS1 and FAS2 by an upstream activation site common to genes involved in membrane lipid biosynthesisH J Schüller, A Hahn, F Tröster, et al.
Environmental Health Perspectives|November 1, 1996
Occurrence of polychlorinated terphenyls (PCTs) in indoor particulate matterU Seidel, E Schweizer, F Schweinsberg, et al.
The Journal of Biological Chemistry|November 5, 1993
Naturally occurring anti-band 3 antibodies bind to protein rather than to carbohydrate on band 3H U Lutz, O Gianora, M Nater, et al.
European Journal of Biochemistry|October 1, 1994
Importance of general regulatory factors Rap1p, Abf1p and Reb1p for the activation of yeast fatty acid synthase genes FAS1 and FAS2H J Schüller, A Schütz, S Knab, et al.
Psychopharmacology Bulletin|January 1, 1990
Benzodiazepine dependence: management of discontinuationK Rickels, W G Case, E Schweizer, et al.
Pageof 26